Investors have found chocolate stocks to be an appealing investment since they have experienced financial gains. As of ...

CRISPR Therapeutics (NASDAQ:CRSP) received an upgrade in its stock rating by analysts at TD Cowen, changing from Sell to Hold, while maintaining a price target of $35.00. The revision in the rating ...

Last week was another busy week for the White House, with several notable Executive Orders and more agency leadership changes ...

The widely followed cryptocurrency analyst Benjamin Cowen is warning that Ethereum (ETH) could slide further against Bitcoin ...

While Michigan's constitution forbids the use of public money for private school, President Trump could sidestep a ...

TD Cowen initiated coverage of Repligen (RGEN) with a Buy rating and $200 price target Repligen is well positioned for “industry-leading” ...

TD Cowen maintained a positive stance on Planet Fitness (NYSE:PLNT) shares, reiterating a Buy rating and a price target of ...

China-based GDS Holdings (GDS) is surging 6% after investment bank TD Cowen raised its price target on the shares. The ...

Metagenomi is a precision genetic medicines company committed to developing curative therapeutics for patients using its ...

A newly discovered asteroid will almost certainly miss the Earth when it comes around in seven years, but eventually one will ...

TD Cowen analyst John Kernan maintained a Hold rating on Under Armour (UAA – Research Report) today and set a price target of $10.00. The ...

Closely followed crypto analyst Benjamin Cowen says that a shift in monetary policy will most likely be what finally triggers an "altseason," or a period where altcoins vastly outperform Bitcoin (BTC) ...